Dr. Kyle Andrew Dallas Den Beste, MD

Dr. Den Beste practices at Orlando Ophthalmology Surgery Center in Orlando, Florida.

Dr. Den Beste's NPI, 1366853731, was assigned on May 19, 2014. Dr. Den Beste graduated from Heersink School of Medicine - Birmingham in 2014. Dr. Den Beste holds Florida license ME139689.

Dr. Den Beste's primary practice is Orlando Ophthalmology Surgery Center, at 105 Bonnie Loch Ct, Orlando, FL 32806. The practice phone is (407) 428-0040.

Dr. Den Beste's primary practice is Orlando Ophthalmology Surgery Center in Orlando, Florida. Dmand AI also links Dr. Den Beste to 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Den Beste practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Den Beste's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Den Beste is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Den Beste's licenses on file in 3 states: Florida, Indiana and Virginia.

Dmand AI lists cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eyelid inflammation, glaucoma, glaucoma surgery and secondary membranaous cataract surgery among the conditions Dr. Den Beste treats.

CMS data shows 610 Medicare services from Dr. Den Beste across 5 procedure codes in 2024, for 410 Medicare patients. Medicare paid $179,040 for them.

CMS counts 410 Medicare patients who saw Dr. Den Beste in 2024. The largest group is 65 to 74, with 210 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 3% are also on Medicaid. Their average risk score is 1.06, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Den Beste's median patient age at 72, with 57% women.

In 2024, Dr. Den Beste wrote 202 Medicare Part D claims for 94 patients. 63% of them were for generic drugs. CMS names the drug for 174 of them, across 6 drugs with 11 or more claims each, at $3,013 in total drug cost. In 2023, CMS named 212 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Den Beste for performance year 2024, reported individually. Dr. Den Beste accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 596 procedures of cataract surgery by Dr. Den Beste, more than 96% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Den Beste, published from 2009 to 2016. 2013 was the busiest year, with 2. The most frequent topics are Epithelial Cells, Microscopy, Confocal and Blotting, Western. Dr. Den Beste has published most often in Int Forum Allergy Rhinol. Dr. Den Beste's most frequent co-authors are Sarah K. Wise, MD, James Michael Cochran, MD, PhD and John M. Delgaudio, MD.

CMS Open Payments shows 39 general payments to Dr. Den Beste from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. Alcon Laboratories Inc paid the most, $1,027.

Dr. Den Beste graduated from Heersink School of Medicine - Birmingham in 2014.

Dr. Den Beste is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.